Current And Emerging Agents For Tinea Pedis
- Volume 27 - Issue 4 - April 2014
- 4273 reads
- 0 comments
1. Evans EG, James IG, Seaman RA, Richardson MD. Does naftifine have anti-inflammatory properties? A double-blind comparative study with 1% clotrimazole/1% hydrocortisone in clinically diagnosed fungal infection of the skin. Br J Dermatol. 1993; 129(4):437-442.
2. Merz Pharmaceuticals, LLC. Naftifine product monograph. 2010.
3. Monk JP, Brogden RN. Naftifine: a review of its antimicrobial activity and therapeutic use as in superficial dermatomycoses. Drugs. 1991; 42(4):659-72.
4. Vago T, Baldi G, Columbo D, et al. Effects of naftifine, terbinafine, two allylamine antifungal drugs, on selected functions of polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1994; 38(11):2605-11.
5. Ablon G, Rosen T, Spedale J. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis. Int J Dermatol. 1996; 35(8):591-93.
6. Parish LC, Parish JL, Routh HB, et al. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine cream, 2% in tinea cruris. J Drugs Dermatol 2011; 10(10):1142-48.
7. Stein Gold L, Parish LC, Vlahovic T, et al. Efficacy and safety of naftifine hcl gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. J Drugs Dermatol. 2013; 12(8):911-918.
8. Tanuma H. Pathogenesis and treatment of hyperkeratotic tinea pedis in Japan. Mycoses. 1999; 42(1-2):21-8.
9. Kircik L and Onumah N. Use of naftifine hydrochloride 2% cream and 39% urea cream in the treatment of tinea pedis complicated by hyperkeratosis. J Drugs Dermatol. 2014; 13(2):162-5.
10. Jarratt M, Jones T, Kempers S, et al. Luliconazole for the treatment of interdigital tinea pedis: a double-blind, vehicle-controlled study. Cutis. 2013; 91(4):203-210.
11. Ikeda S, Kanoya Y, Nagata S. Effects of a foot bath containing green tea polyphenols on interdigital tinea pedis. Foot. 2013; 23(2-3):58-62.
12. Bonifaz A, Vazquez-Gonzalez D, Hernandez MA, et al. Dermatophyte isolation in the socks of patients with tinea pedis and onychomycosis. Japan Derm Assoc. 2013; 40(6):504-505.
13. Hammer TR, Mucha H, Hoefer D. Infection risk by dermatophytes during storage and after domestic laundry and their temperature-dependent inactivation. Mycopathologia 2011; 171(1):43-49.
14. Borkow G and Mellibovsky JC. Resolution of skin maladies of the trapped Chilean miners: the unplanned underground copper-impregnated antifungal socks “trial.” Arch Dermatol. 2012; 148(1):134-136.
15. Borkow G, Gabbay J. Copper as a biocidal tool. Curr Med Chem. 2005; 12(18):2163-2175.
16. Tanaka K, Katoh T, IrimajiriI J, et al. Preventive effects of various types of footwear and cleaning methods on dermatophyte adhesion. J Dermatol. 2006; 33(8):528.
17. Ghannoum MA, Isham N, and Long L. Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device. J Am Podiatr Med Assoc. 2012; 102(4):309.